EP2229356
1,2-DISUBSTITUTED-4-BENZYLAMINO-PYRROLIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLI PIDEMIA OR ARTERIOSCLEROSIS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.12.2008EP published:
12.10.2011EP application number:
08857355.5
EPO information:
European Patent Register
Title:
1,2-DISUBSTITUTED-4-BENZYLAMINO-PYRROLIDINE DERIVATIVES AS CETP INHIBITORS USEFUL FOR THE TREATMENT OF DISEASES SUCH AS HYPERLI PIDEMIA OR ARTERIOSCLEROSIS
Timeline
Today
1.12.2008EP application
12.10.2011EP Publication
Owner
Name:
Novartis AGAddress:
Lichtstrasse 35, 4056, Basel, CH
Inventor
Name:
MOGI, MunetoAddress:
WalthamMassachusetts, US
Name:
KAWANAMI, ToshioAddress:
BostonMassachusetts, US
Name:
YAMADA, KenAddress:
BostonMassachusetts, US
Name:
YASOSHIMA, KayoAddress:
CambridgeMassachusetts, US
Name:
IMASE, HidetomoAddress:
CambridgeMassachusetts, US
Name:
MIYAKE, TakahiroAddress:
Kobe-shiHyogo, JP
Name:
OHMORI, OsamuAddress:
Izunokuni-shiShizuoka, JP
Priority
Number:
991891 PDate:
3.12.2007Country:
US
Classification
Categories:
C07D 207/14, C07D 403/12, C07D 403/14, C07D 401/14, C07D 405/14, C07D 413/14, A61K 31/40, A61P 3/06